X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (305) 305
oncology (216) 216
double-blind (177) 177
female (162) 162
male (147) 147
antiemetics - therapeutic use (140) 140
vomiting - chemically induced (137) 137
plus dexamethasone (136) 136
chemotherapy (132) 132
middle aged (126) 126
vomiting - prevention & control (125) 125
adult (121) 121
aged (108) 108
antineoplastic agents - adverse effects (105) 105
index medicus (103) 103
ondansetron (102) 102
cisplatin-induced emesis (101) 101
nausea (97) 97
nausea - chemically induced (97) 97
high-dose metoclopramide (93) 93
prevention (93) 93
nausea - prevention & control (84) 84
cisplatin (74) 74
metoclopramide (69) 69
treatment outcome (68) 68
drug therapy, combination (67) 67
pharmacology & pharmacy (66) 66
cisplatin - adverse effects (65) 65
induced nausea (65) 65
neoplasms - drug therapy (62) 62
dexamethasone - therapeutic use (61) 61
dexamethasone (60) 60
antiemetics (57) 57
ondansetron plus dexamethasone (57) 57
antiemetics - administration & dosage (50) 50
cancer (50) 50
moderately emetogenic chemotherapy (50) 50
vomiting (50) 50
double-blind method (49) 49
prophylaxis (49) 49
medicine & public health (48) 48
ondansetron - therapeutic use (48) 48
randomized trial (48) 48
combination (46) 46
antineoplastic combined chemotherapy protocols - adverse effects (45) 45
serotonin antagonists - therapeutic use (44) 44
vomiting - drug therapy (43) 43
antiemetics - adverse effects (39) 39
dexamethasone - administration & dosage (39) 39
granisetron (39) 39
antineoplastic combined chemotherapy protocols - therapeutic use (38) 38
cancer-chemotherapy (37) 37
drug therapy (37) 37
adolescent (36) 36
delayed emesis (35) 35
emesis (35) 35
induced emesis (35) 35
metoclopramide plus dexamethasone (35) 35
intravenous ondansetron (33) 33
serotonin antagonist (33) 33
antiemetic efficacy (32) 32
health care sciences & services (32) 32
metoclopramide - therapeutic use (32) 32
nausea - drug therapy (32) 32
drug administration schedule (31) 31
efficacy (31) 31
medicine, general & internal (31) 31
rehabilitation (31) 31
prospective studies (30) 30
dose-response relationship, drug (29) 29
animals (28) 28
antineoplastic agents - therapeutic use (28) 28
placebo (28) 28
randomized controlled trials as topic (28) 28
ondansetron - administration & dosage (27) 27
placebo-controlled trial (27) 27
aged, 80 and over (26) 26
breast-cancer (26) 26
care and treatment (26) 26
cisplatin - administration & dosage (26) 26
child (25) 25
administration, oral (24) 24
chemotherapy-induced nausea (24) 24
postoperative nausea and vomiting - prevention & control (24) 24
surgery (24) 24
trial (24) 24
anesthesiology (23) 23
multicenter (23) 23
diphenhydramine (22) 22
research (22) 22
clinical trials as topic (21) 21
granisetron - therapeutic use (21) 21
high-dose cisplatin (20) 20
lung neoplasms - drug therapy (20) 20
phase-iii (20) 20
quality of life (20) 20
randomized-trial (20) 20
hematology (19) 19
crossover (18) 18
internal medicine (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Chemical & Engineering Data, ISSN 0021-9568, 05/2014, Volume 59, Issue 5, pp. 1700 - 1703
In the present investigation, the solubility of metoclopramide hydrochloride (MHCl) in six green solvents, namely water, ethanol, propylene glycol (PG),... 
P-TOLUIC ACID | ENGINEERING, CHEMICAL | THERMODYNAMICS | PLUS WATER MIXTURES | MAGNESIUM-DL-ASPARTATE | INDOMETHACIN | ETHANOL | GLYCOL | CHEMISTRY, MULTIDISCIPLINARY | PREDICTION
Journal Article
Journal Article
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 07/2017, Volume 15, Issue 7, pp. 883 - 893
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and... 
INDUCED EMESIS | CHEMOTHERAPY-INDUCED NAUSEA | PLUS DEXAMETHASONE | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | DOUBLE-BLIND | CISPLATIN-INDUCED NAUSEA | RADIOTHERAPY-INDUCED NAUSEA | HIGH-DOSE METOCLOPRAMIDE | PHASE-I | RECEPTOR ANTAGONIST
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 1991, Volume 14, Issue 3, pp. 238 - 242
Journal Article
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2006, Volume 17, Issue 1, pp. 20 - 28
Journal Article
British Journal of Cancer, ISSN 0007-0920, 07/1993, Volume 68, Issue 1, pp. 176 - 180
The anti-emetic efficacy and safety of granisetron, a highly selective and potent 5-HT3 receptor antagonist, was compared with that of high-dose metoclopramide... 
TRIALS | ANTIEMETIC ACTIVITY | LORAZEPAM | PLUS DEXAMETHASONE | ONCOLOGY | DIPHENHYDRAMINE | DOUBLE-BLIND | NAUSEA | CHEMOTHERAPY
Journal Article